SEC Form 4 · Insider disclosures

Recent Insider Selling

Recent sales grouped by company, with disclosed plans and holdings context. A sale alone does not establish a bearish view.

Updates are delayed; the last verified disclosures remain available.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

1 companies · 4 rows
CUE

Cue Biopharma, Inc.

Sale total ≈ US$389.3K

4 transaction rows · 3 filings

Ray Sumita

Sale
Officer disclosed sale of 1,844 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 1.55% of prior direct holdings; approximately 117K shares remain

Calculated transaction value approximately US$51.72K

Meluzio Michael Vincent

Sale
Officer disclosed sale of 1,144 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 2.33% of prior direct holdings; approximately 47.8K shares remain

Calculated transaction value approximately US$32.09K
Show 2 more transaction rows

Lin Shao-Lee

Sale
CEO / Director disclosed sale of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 696K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$275K

Lin Shao-Lee

Sale
CEO / Director disclosed sale of 1,087 shares

Filing did not check the 10b5-1 plan indicator

Approximately 695K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$30.49K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗